Adding GBT Technologies (GTCH) to the Watch List.
Massive Potential From California Based Technology Think Tank.
Yes, risky - as in...
Adding Auris Medical (EARS) $3.50 to Biotech Watch List.
Auris Medical soared 590% in one Week on Covid Related News on December 1st, 2020.
LIFT OFF...
Hapbee (HAPBF) Selects Accomplished Technology and Consumer Products Entrepreneur & Executive as CEO.
Transformational Entrepreneur Yona Shtern to Lead Hapbee as it Advances Commercialization Phase of Business Development
VANCOUVER, BC, June 2, 2021 /PRNewswire/...
GBT (GTCH) Is Researching To Develop An AI Empowered, Wireless Patient Health Monitoring System
The researched technology, is aiming to create a Radio-Based patient health monitoring system for homes or facilities
SAN...
Stocks On The Move!
Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the...
Provention Bio (PRVB) Updates.
LATEST UPDATE July 13th, 2022, below.
(2021) We're getting way too many calls on...
Adding Hapbee Tech (HAPB, HAPBF) $0.34 to Biotech Six Pack Watch List.
UPDATE ON BIOTECH SIX PACK, SIX STOCKS WE EXPECT TO DOUBLE.
While the Biotech Stock Review was launched...
Discontinuing Coverage on Dalrada (DFCO).
We Are Temporarily Discontinuing Coverage on Dalrada Financial.
Great little company and we're up 400%. But with the market...
Aphex BioCleanse Further Expands Distribution Channels.
Aphex BioCleanse Systems Announces Partnership With Bifulco Consulting Group to Expand Distribution Channels
PITTSFORD, N.Y., May 20, 2021...
Citius Pharma (CTXR) Updates Shareholders.
Citius Update Stem Cell Study
Citius Pharmaceuticals, Inc announced that it will present a poster at the International Society...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
